|
Empowering Black Girls May Help to Reduce Drug Use, YSPH Study Finds
 Black girls make up a relatively small portion of the overall drug-using population. But their health consequences are more severe than most: Reproductive issues, fertility issues, sexually transmitted infections and trauma exposure are all obstacles they face at statistically higher rates compared to their peers.
And when confronted with overlapping issues such as oppression and powerlessness, Black girls may engage in more risk taking and addictive behaviors like drug use, researchers have found - all while existing mentoring programs and prevention strategies are rarely tailored to their experiences.
A new study led by Yale School of Public Health assistant professor, Ijeoma Opara, suggests that empowering Black girls to feel in control of their social environment and proud of their identity may help to reduce these trends.
More from Yale School of Public Health
RECRUITING: Applications are open for CIRA’s two Fellowships programs, Yale AIDS Prevention Training Program (Y-APT) and the Research Education Institute for Diverse Scholars (REIDS)
 Y-APT is a full time, two-year Postdoctoral T32 Fellowship for scholars with PhD, MD, and/or JD degrees. Fellows work closely with their Yale mentors focusing on professional development, productivity, and networking. Application deadline is December 3, 2021.
REIDS is a two-year R25 educational program for racial and ethnic minority researchers dedicated to reducing HIV inequities in communities of color, particularly early career faculty and postdoctoral researchers. REIDS provides research training, professional development and team mentoring in four-week immersive institutes over two summers and monthly meetings throughout the year. Application deadline is February 4, 2022.
Further information and applications
Addressing the Intertwined Opioid, HIV, and HCV Crises: Q&A With Rick Altice
 In 2019, drug overdoses took the lives of more than 70,000 people in the United States. In West Virginia, which sees the greatest overdose rate in the U.S., recent legislation has substantially undermined syringe services program (SSP) delivery, which is a major part of the public health toolkit to prevent transmission of HIV and HCV (hepatitis C virus) infections and overdose from opioids. In the absence of what were widely available SSPs, the remaining tools involve clinicians in primary care who have the ability to screen for, treat, and prevent these adverse outcomes, especially in rural communities where services are limited.
More from Yale School of Medicine
- Finding Solutions to the Opioid Crisis: The Crime of the Century - Big Pharma and the American Overdose Crisis
Date: Tuesday, October 5, 12:00 pm-1:30 pm
Presenters: Alex Gibney, Creator and Director, HBO's The Crime of the Century, and Patrick Radden Keefe, The New Yorker
Host: Yale Program in Addiction Medicine
Further Details
- Yale School of Public Health Epidemiology of Microbial Diseases Seminar Series: "40 Years of HIV Vaccine Development: Lessons Learned"
Date: Wednesday, October 6, 12:00 pm-1:00 pm
Presenter: Stuart Shapiro, MD, PhD, Vaccine Research Program, Division of AIDS/NIAID
Further Details
- Integration of opioid use disorder and HIV treatment among persons involved in the justice system is not only smart, it is the right thing to do!
Date: Friday, October 8, 12:00 pm
Presenter: Sandra A. Springer, MD, Yale School of Medicine
Further Details
- Journal of the International AIDS Society (JIAS) Symposium: Global Mental Health and HIV Prevention and Care
Date: Tuesday, October 12, 9:30 am-10:30 am
Further Details
- YSPH Social & Behavioral Sciences Seminar Series: "The role of gentrification in shaping the religious landscape of American communities: Implications for health, social, and economic futures of disenfranchised populations"
Date: Tuesday, October 12, 12:00 pm-1:00 pm
Presenter: Yusuf Ransome, Yale School of Public Health
Audience: Yale Only
Further Details
- People+Purpose+Power: Free October Presentations
Date: Thursday, October 14
- Connecting Paradigms: 10:00 am-12:00 pm
- Self-Care is Quality Care: 1:00 pm-3:00 pm
Presented by the New Haven/Fairfield Ryan White Part A Program
Further Details
- CONFERENCE: Through the eyes of She: Equity in Health, Education, Business and Leadership for the African Woman in the 21st Century'
Date: October 15-16
This conference will tackle the challenge of gender equality and the empowerment of women on the African continent.
Further Details
- CIRA Qualitative Research Discussion Group (QRDG): "Contact Tracing in the Era of COVID-19: A Multiple Methods Implementation Evaluation"
Date: Friday, October 15, 12:00 pm-1:30 pm
Presenter: Tyler Shelby, Yale School of Public Health
Contact: Lauretta Grau (lauretta.grau@yale.edu)
Further Details
- The Inter-CFAR Substance Use Community (I-SURC) presents Preventing HIV in People who use Substances: A Symposium
Date: Tuesday, October 26, 12:00 pm-1:30 pm
Registration
- Call for Nominations: 2021 RWJF-AIDS United Award for Health Equity
Nomination Due Date: October 15, 2021
Further Details
- Call for Papers: Addressing Disparities to Promote Health Equity and Healthcare Quality (Journal for Healthcare Quality)
Submission Due Date: November 15, 2021
Further Details
- Call for Abstracts: Ageing with HIV (Journal of the International AIDS Society)
Submission Due Date: December 1, 2021
Further Details
Download an Excel spreadsheet compilation of active funding opportunities. Opportunities previously not listed are below.
- Doris Duke Clinical Scientist Development Award (CSDA)
Exemption Request Deadline: October 15 at 5:00 pm
Pre-proposal Applications Due Date: November 12 at 3:00 pm
An informational webinar will be held on October 1, 2021 at 12:00 pm (registration required).
Further Details
- Comprehensive High-Impact HIV Prevention Programs for Young Men of Color Who Have Sex with Men and Young Transgender Persons of Color
Application Due Date: November 19, 2021
Further Details
- Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries (R34 Clinical Trial Optional)
Application Due Date: December 9, 2021
Further Details
- The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional)
Application Due Date(s): December 15, 2021/2022/2023
Further Details
- Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional)
AIDS Application Due Date(s): December 20, 2021/2022
Further Details
- Brief Report: Are Serious Falls Associated With Subsequent Fragility Fractures Among Veterans Living With HIV?
Julie A Womack, Terrence E Murphy, Christine Ramsey, Harini Bathulapalli, Linda Leo-Summers, Alexandria C Smith, Jonathan Bates, Samah Jarad, Thomas M Gill, Evelyn Hsieh, Maria C Rodriguez-Barradas, Phyllis C Tien, Michael T Yin, Cynthia Brandt, Amy C Justice
Journal of Acquired Immune Deficiency Syndromes. 2021 Oct 1;88(2):192-196. doi: 10.1097/QAI.0000000000002752.
- Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIV
Jessica J Wyse, Kathleen A McGinnis, E Jennifer Edelman, Adam J Gordon, Ajay Manhapra, David A Fiellin, Brent A Moore, P Todd Korthuis, Amy J Kennedy, Benjamin J Oldfield, Julie R Gaither, Kirsha S Gordon, Melissa Skanderson, Declan T Barry, Kendall Bryant, Stephen Crystal, Amy C Justice, Kevin L Kraemer
AIDS and Behavior. 2021 Sep 8. doi: 10.1007/s10461-021-03452-0. Online ahead of print.
- Prevalence and correlates of non-fatal overdose among people who use drugs: findings from rapid assessments in Massachusetts, 2017-2019
Shikhar Shrestha, Thomas J Stopka, Jaclyn M W Hughto, Patricia Case, Wilson R Palacios, Brittni Reilly, Traci C Green
Harm Reduction Journal2021. Aug 30;18(1):93. doi: 10.1186/s12954-021-00538-9.
NOTE: All times are expressed in Eastern Time unless otherwise noted. All dates refer to 2021 unless otherwise noted.
|
